Assistechsp. z o.o.

Manufacture of irradiation, electromedical and electrotherapeutic equipment

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-06-05
Share capital
100 050,00 PLN
Activity description

Assistech is a manufacturer of medical technology specializing in communication and rehabilitation solutions for individuals with neurological disorders. Their products include C-Eye ® X, C-Eye ® X PRO, neuroTAB, eyefeel ®, and eyeLearn. The company is supported by funding from PFRON as part of a program aimed at eliminating barriers in communication.

Registered address
ul. Kampinoska 10, 80-180 Gdańsk, Poland
Website
assistech.euWebsite active
Email
Email address current
Phone
Social media
Electronic delivery address
AE:PL-89886-90504-ARCET-14

Financials

Revenue history (in k)

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.80mMedianUSD 100.52kAverageUSD 1.75m
Net profit
This companyUSD -54.76kMedianUSD -236.17AverageUSD 117.58k
Operating costs
This companyUSD 1.83mMedianUSD 151.45kAverageUSD 1.56m
Assets
This companyUSD 1.24mMedianUSD 293.53kAverageUSD 2.05m

Bank accounts

Registered as a VAT taxpayer on 2014-06-10. Active

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Real estate

TypeAmount
Buildings and premises
PLN 119.4K

Public aid

37 public aid cases recorded, with a total value of $1,450,686.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$7,956
De minimis aid (in accordance with Commission Regulation 2023/2831)
$3,822
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,564

European Funds

ProjectEU co-financing
Internacjonalizacja AssisTech Sp. z o.o. poprzez wprowadzenie produktu C-Eye na rynki międzynarodowe.
$90,624
Wzrost konkurencyjności AssisTech sp. z o.o. z Gdańska poprzez inwestycję umożliwiającą rozpoczęcie samodzielnej produkcji elementów Systemu C-Eye
$15,984

Tenders

7 tenders recorded as contractor: 5 national ($60,327) and 2 EU ($105,844).

SubjectAmount
Dostawa urządzeń i oprogramowań wspomagających osoby z różnymi niepełnosprawnościami
–
Dostawa sprzętu medycznego oraz rehabilitacyjnego dla Wojewódzkiego Szpitala Rehabilitacyjnego im. dr. S. Jasińskiego w Zakopanem
$27,693
Zakup sprzętu do owit
$95,196

Public sector contracts

Assistech is the contractor in one public sector contract, worth PLN 22.22k.

Public buyerValue
Specjalny Ośrodek Szkolno - Wychowawczy Im. Biskupa z Miry Świętego Mikołaja w ŻukowiePLN 22,222

Trademarks

Assistech holds 6 active trademarks registered with the Polish Patent Office. 2 marks have expired or were not registered. The first mark was filed in 2011.

MarkProtected until
eyeLearnAug 18, 2030
eyeLearn(word)Apr 3, 2030
eduVery(word)Mar 6, 2030
cyberoko(word)Nov 5, 2028
c-eye(word)Dec 16, 2034

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Authorized Representatives

Bartosz Krzysztof Kunka – President of the Management Board
Robert Karol Kosikowski – Vice President of the Management Board

Manner of representation

The company is represented by each member of the management board independently, or by a commercial proxy (if appointed).

Ownership

OwnerSharesShare valueStake
Robert Karol Kosikowski (42)
971$13,114.5348.5257%
Bartosz Krzysztof Kunka (43)
971$13,114.5348.5257%
Others
59$796.872.9486%

Beneficial owners

Person

Competitors

Name
Kontakt Micro-Locationsp. z o.o.
Feedtechsp. z o.o.
Pro-PlusS.A.
Mescomp TechnologiesS.A.
Emproxsp. z o.o.
QvitiS.A.
Silsense TechnologiesS.A.
PIRS Creative Labsp. z o.o.
Blink.Prosp. z o.o.

Change history

DateEvent
2024-07-09Address change
2021-12-08Share capital change
2017-12-19Share capital change
2017-04-19PKD change
2016-07-11Share capital change

FAQ

Last updated: 2026-07-09